Trade Bolt Biotherapeutics, Inc. - BOLT CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.0095 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.02629% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.004068% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 0.7332 |
| Open | 0.7332 |
| 1-Year Change | -44.36% |
| Day's Range | 0.7319 - 0.7473 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jul 25, 2024 | 0.7332 | 0.0060 | 0.83% | 0.7272 | 0.7332 | 0.7182 |
| Jul 24, 2024 | 0.7271 | -0.0052 | -0.71% | 0.7323 | 0.7326 | 0.7271 |
| Jul 23, 2024 | 0.7273 | -0.0100 | -1.36% | 0.7373 | 0.7452 | 0.7172 |
| Jul 22, 2024 | 0.7206 | -0.0266 | -3.56% | 0.7472 | 0.7472 | 0.7172 |
| Jul 19, 2024 | 0.7272 | -0.0200 | -2.68% | 0.7472 | 0.7472 | 0.7172 |
| Jul 18, 2024 | 0.7372 | 0.0140 | 1.94% | 0.7232 | 0.7477 | 0.7232 |
| Jul 17, 2024 | 0.7328 | -0.0085 | -1.15% | 0.7413 | 0.7424 | 0.7171 |
| Jul 16, 2024 | 0.7473 | 0.0333 | 4.66% | 0.7140 | 0.7523 | 0.7140 |
| Jul 15, 2024 | 0.7264 | -0.0008 | -0.11% | 0.7272 | 0.7416 | 0.7181 |
| Jul 12, 2024 | 0.7403 | 0.0331 | 4.68% | 0.7072 | 0.7502 | 0.7072 |
| Jul 11, 2024 | 0.7273 | 0.0101 | 1.41% | 0.7172 | 0.7342 | 0.7072 |
| Jul 10, 2024 | 0.7173 | -0.0004 | -0.06% | 0.7177 | 0.7250 | 0.7072 |
| Jul 9, 2024 | 0.7187 | -0.0035 | -0.48% | 0.7222 | 0.7272 | 0.7081 |
| Jul 8, 2024 | 0.7223 | 0.0051 | 0.71% | 0.7172 | 0.7328 | 0.7172 |
| Jul 5, 2024 | 0.7173 | -0.0099 | -1.36% | 0.7272 | 0.7272 | 0.7172 |
| Jul 3, 2024 | 0.7321 | 0.0149 | 2.08% | 0.7172 | 0.7323 | 0.7102 |
| Jul 2, 2024 | 0.7322 | 0.0150 | 2.09% | 0.7172 | 0.7322 | 0.7172 |
| Jul 1, 2024 | 0.7222 | -0.0045 | -0.62% | 0.7267 | 0.7312 | 0.7185 |
| Jun 28, 2024 | 0.7427 | 0.0230 | 3.20% | 0.7197 | 0.7427 | 0.7172 |
| Jun 27, 2024 | 0.7392 | 0.0220 | 3.07% | 0.7172 | 0.7470 | 0.7172 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Bolt Biotherapeutics, Inc. Company profile
About Bolt Biotherapeutics Inc
Bolt Biotherapeutics, Inc is a clinical-stage immuno-oncology company. The Company is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. Its Immune-Stimulating Antibody Conjugate (ISAC) approach uses immunostimulants to engage and activate myeloid cells, including macrophages and dendritic cells, that kill tumor cells via phagocytosis and expose tumor neoantigens to the adaptive immune system. The Company’s product candidate BDC-1001 is a human epidermal growth factor receptor 2 (HER2) Boltbody ISAC comprised of a HER2-targeting biosimilar, of trastuzumab conjugated to one of its TLR7/8 agonists, for the treatment of patients with HER2-expressing solid tumors, including those with HER2-low tumors. Its Toll-like receptors (TLRs) activate myeloid cells and enable the presentation of tumor-associated neoantigens to cytotoxic T cells.
Financial summary
BRIEF: For the nine months ended 30 September 2021, Bolt Biotherapeutics Inc revenues increased from $231K to $752K. Net loss increased from $29.7M to $71.4M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Research and d increase of 99% to $49.8M (expense), Fair Value Adjustments on Other Assets decrease from $2.4M (income) to $6.1M (expense).
| Industry: | Bio Therapeutic Drugs |
900 Chesapeake Drive
REDWOOD CITY
CALIFORNIA 94063
US
News
How to manage risk when trading
Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.
06:57, 22 July 2024
ECB preview: lack of new data sees markets expecting a hold
Markets expect the ECB to keep rates unchanged in July but expectations for a September cut rise
13:13, 18 July 2024
What is an IPO and how does it work?
Learn about what an IPO is, why they are important, and how they work.
07:19, 10 July 2024
What are the biggest stock exchanges worldwide?
Discover the largest stock exchanges in the world by market capitalisation, including the Nasdaq Stock Market, the New York Stock Exchange and the London Stock Exchange.
12:44, 9 July 2024
Top ETFs
ETFs, or exchange-traded funds, offer traders a versatile gateway into the financial markets.
16:23, 8 July 2024
Lloyds forecast: will Lloyds share price return to £1? Third party data forecast
What’s next for Lloyds amid higher inflation and the start of a potential recessionary cycle in the UK?
14:00, 8 July 2024
RBNZ Preview: OCR expected to remain unchanged as central bank focuses on inflation
The Reserve Bank of New Zealand meets on Wednesday, July 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
13:25, 8 July 2024People also watch
Still looking for a broker you can trust?
Join the 630,000+ traders worldwide that chose to trade with Capital.com